Effects Of Caffeine On Cognitive Performance

Sponsor
University of Castilla-La Mancha (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05995314
Collaborator
(none)
30
1
3
28
32.6

Study Details

Study Description

Brief Summary

Caffeine is a potent central nervous system stimulant that increases the activity in the prefrontal cortex and can improve cognitive skills. An improvement in these cognitive skills can lead to further benefits in athletic performance. Therefore, it is necessary to clarify the dose-response of caffeine on cognitive performance.The aim of this research will be to determine the effects of different doses of caffeine on sport-related cognitive aspects.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: PLACEBO
  • Dietary Supplement: 3 mg/kg of caffeine
  • Dietary Supplement: 6 mg/kg of caffeine
N/A

Detailed Description

The investigators will require healthy, physically active young adults to complete three trials under the conditions: a) placebo, b) 3 mg/kg, or c) 6 mg/kg body mass of caffeine. In each trial, different cognitive abilities will be assessed using the following test batteries: reaction time (DynavisionTM D2), anticipation (Bassin Anticipation Timer), sustained attention (Go/No-Go and Eriksen Flanker Test) and memory tests. In addition, side effects and the perceived sensation index will be recorded 24 h after each test.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
To achieve the blinded placebo situation, a researcher not associated with the study will be performed the blinding and prepared identical capsules containing placebo or the corresponding dose of caffeine. This researcher will be assigned an alphanumeric code to each trial to blind participants and investigators
Primary Purpose:
Other
Official Title:
Effects Of Different Doses Of Caffeine On Cognitive Performance In Healthy Physically Active Individuals
Actual Study Start Date :
Aug 7, 2023
Anticipated Primary Completion Date :
Sep 4, 2023
Anticipated Study Completion Date :
Sep 4, 2023

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: PLACEBO

placebo (0 mg/kg of body mass of caffeine). The capsule will be filled with 3 mg/kg of body mass of cellulose.

Dietary Supplement: PLACEBO
3 mg/kg of cellulose (0 mg/kg of caffeine)

Experimental: 3mg/kg

3 mg/kg of body mass of caffeine (99% caffeine, Bulkpowders, United Kingdom).

Dietary Supplement: 3 mg/kg of caffeine
Ingestion of 3 mg/kg of body mass of caffeine

Experimental: 6mg/kg

6 mg/kg of body mass of caffeine (99% caffeine, Bulkpowders, United Kingdom).

Dietary Supplement: 6 mg/kg of caffeine
Ingestion of 6 mg/kg of body mass of caffeine

Outcome Measures

Primary Outcome Measures

  1. Reaction Time [10 minutes]

    Reaction time (in seconds) shall be assessed with the Dynavision™ D2 Visomotor Device using the "Reaction Time Test". In this test the fastest visual, motor and physical reaction time will be measured.

  2. Anticipation [5 minutes]

    Visual acuity related to hand-eye coordination and anticipation will be assessed using the Bassin Anticipation Timer instrument. The best anticipation time (in seconds) of each condition (5, 10 and 15 mph) will be taken.

  3. Sustained attention [10 minutes]

    The ability of maintaining the attention and inhibiting an appropriate response will be measured by "Go/No-Go Test" [fastest, slowest, and average response time (in seconds), and successful attempts (percentage; %)] and "Eriksen Flanker Test" [congruent and incongruent reaction time (in seconds)].

  4. Memory [20 minutes]

    To study the modulation of memory storage processes, three 20-item word lists were created. Each word in the list will be presented for 5 s. This will be followed by a 100 s memory consolidation interval, after which there will be a 120 s period in which as many words as the participants can remember will be written down (First time). After 15 min, participants will perform a recall task (Second time) in which they will have to rewrite all the words they remember at that time.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Physically active individuals ( >150 min/week moderate physical activity or >75 min/week vigorous physical activity)

  • Individuals without serious and undiagnosed health problems.

Exclusion Criteria:
  • Individuals with color blindness.

  • Regular caffeine consumers (>3 cups of coffee/day).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Performance and Sport Rehabilitation Laboratory Toledo Spain 45071

Sponsors and Collaborators

  • University of Castilla-La Mancha

Investigators

  • Study Director: Javier Abián-Vicén, PhD, University of Castilla-La Mancha

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Castilla-La Mancha
ClinicalTrials.gov Identifier:
NCT05995314
Other Study ID Numbers:
  • CAF_MR_2023
First Posted:
Aug 16, 2023
Last Update Posted:
Aug 18, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Castilla-La Mancha
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 18, 2023